siRNA, Anti-BTG1, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT01466WQ-2OMe)

The product SIRGT01466WQ-2OMe is a type of small interfering RNA (siRNA) that targets BTG1 gene and regulates the expression of gene. The siRNA interferes with the expression of BTG1 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_001731.2
Alternative Names APRO2
Related Diseases Lymphocytic Leukemia
Purification HPLC
Target Gene
Gene ID 694
Uniprot ID P62324
Sub Cat Target Species Modification Scale  
SIRGT02466WQ-2F BTG1 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT03466WQ-2MOE BTG1 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT04466WQ-LNA BTG1 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT01466WQ-RB BTG1 Human Ribo-modified Inquiry
SIRGT02466WQ-BB BTG1 Human Backbone-modified Inquiry

Related Products